中度高氯血症对连续输注高渗盐水治疗的脑出血患者临床结局的影响:一项先导研究
这项多中心回顾性倾向匹配队列研究纳入2011年9月至2015年9月间两家学术医学中心神经重症监护病房出院的脑出血患者,均接受连续静脉输注3%高渗盐水治疗。未匹配队列219例(中度高氯血症143例,非高氯血症76例),倾向匹配队列100例。匹配队列中,发生中度高氯血症者院内死亡率显著更高(34% vs 14%,p=0.02);多因素logistic回归显示中度高氯血症独立预测院内死亡(OR 4.4,95%CI 1.4-13.5,p=0.01)。作者认为高渗盐水治疗期间应密切监测氯离子值。
要点
- 脑出血患者连续静脉输注3%高渗盐水期间,发生中度高氯血症(氯≥115 mmol/L)者匹配队列院内死亡率为34%,非高氯血症者为14%(p=0.02)。
- 多因素logistic回归显示中度高氯血症独立预测院内死亡(OR 4.4,95%CI 1.4-13.5,p=0.01)。
- 研究为多中心回顾性倾向匹配队列研究,未匹配队列219例(高氯143例 vs 非高氯76例),匹配队列100例。
- 作者认为高渗盐水治疗期间应密切监测氯离子值,因中度升高可能影响脑出血患者结局。
适用人群与场景
- 2011年9月至2015年9月间两家学术医学中心神经重症监护病房出院的脑出血患者,均接受连续静脉输注3%高渗盐水治疗。
诊断标准与关键阈值
- 中度高氯血症定义为氯离子≥115 mmol/L。
处置流程与药物剂量
- 连续静脉输注3%高渗盐水(原文未写明具体剂量、速度及疗程)。
研究设计与关键结果
- 研究类型为多中心、回顾性、倾向匹配队列研究,纳入两家学术医学中心神经重症监护病房的脑出血患者,均接受连续静脉输注3%高渗盐水。
- 未匹配队列共219例,其中中度高氯血症143例、非高氯血症76例;倾向匹配队列100例。
- 匹配队列中,中度高氯血症组院内死亡率为34%,非高氯血症组为14%,差异显著(p=0.02)。
- 多因素logistic回归分析显示,中度高氯血症独立预测院内死亡(OR 4.4,95%CI 1.4-13.5,p=0.01)。
证据类型、等级与局限
- 证据类型:多中心回顾性倾向匹配队列研究(先导研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高渗盐水治疗期间应密切监测氯离子值,因为中度升高可能影响脑出血患者的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Hyperchloremia has been associated with increased morbidity and mortality in critically ill patients. While previous research has demonstrated an association between hypertonic saline and hyperchloremia, limited data exist in neurocritical care patients. The objective of this study is to determine the impact of moderate hyperchloremia (chloride ≥ 115 mmol/L) on clinical outcomes in intracerebral hemorrhage patients treated with continuous IV infusion 3% hypertonic saline.
DESIGN: Multicenter, retrospective, propensity-matched cohort study.
SETTING: Neurocritical care units at two academic medical centers with dedicated neurocritical care teams and comprehensive stroke center designation.
PATIENTS: Intracerebral hemorrhage patients discharged between September 2011 and September 2015 were evaluated and matched 1:1 based on propensity scoring.
INTERVENTIONS: Continuous IV infusion 3% hypertonic saline.
MEASUREMENTS AND MAIN RESULTS: A total of 219 patients were included in the unmatched cohort (143 moderate hyperchloremia and 76 nonhyperchloremia) and 100 patients in the propensity-matched cohort. In-hospital mortality was significantly higher in those who developed moderate hyperchloremia in a propensity-matched cohort (34% vs 14%; p = 0.02). Moderate hyperchloremia independently predicted in-hospital mortality in multivariable logistic regression analysis (odds ratio, 4.4 [95% CI, 1.4-13.5]; p = 0.01).
CONCLUSIONS: We observed higher rates of in-hospital mortality in patients who developed moderate hyperchloremia during treatment with continuous IV infusion 3% hypertonic saline, with moderate hyperchloremia independently predicting in-hospital mortality. These results suggest that chloride values should be monitored closely during hypertonic saline treatment as moderate elevations may impact outcomes in intracerebral hemorrhage patients.
参考来源
- Riha HM, Erdman MJ, Vandigo JE, et al. Impact of Moderate Hyperchloremia on Clinical Outcomes in Intracerebral Hemorrhage Patients Treated With Continuous Infusion Hypertonic Saline: A Pilot Study. Crit Care Med. 2017. PMID: 28538442. doi:10.1097/CCM.0000000000002522
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。